The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Ralf Mueller
Showing 1-5 of 5 articles
Substitution of ethanol with specially designed microspheres in a TASH procedure
Latsios G,
Gerckens U,
Mueller R,
Grube E
February 21, 2011
Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)
Godino C,
Parodi G,
Furuichi S,
Latib A,
Barbagallo R,
Goktekin O,
Cera M,
Mueller R,
Tamburino C,
Grube E,
Di Mario C,
Reimers B,
Chieffo A,
Antoniucci D,
Colombo A,
Sangiorgi G
April 12, 2010
One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial
Stella P,
Mueller R,
Pavlakis G,
De Bruyne B,
Hauptmann K-E,
Morice M,
Chevalier B,
Fajadet J,
Sievert H,
Grube E
August 20, 2008
Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results
Grube E,
Sievert H,
Hauptmann K-E,
Mueller R,
Gerckens U,
Buellesfeld L,
Ako J,
Shimohama T,
Costa M,
Fitzgerald P
May 13, 2008
Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study
Grube E,
Baim D,
Burkhoff D,
Mueller R,
Buellesfeld L,
Teirstein P
November 20, 2005
1
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke